Anthony is a Partner at Alantra with over 15 years of M&A experience in the healthcare sector.
He is recognised as one of the leading advisors in the pharma services sector. Anthony has worked on more than 40 M&A transactions and a variety of strategic advisory projects for a range of clients in the UK, US, Europe and Asia.
Prior to joining Alantra, Anthony held positions in the healthcare teams at Bear Sterns and Rothschild. He has advised high-profile pharma services business including Cherry Healthcare on its sale to Avenir Global, Prescient Healthcare Group on the investment from Baird Capital, Lucid Group on the investment from LDC, STEM on its £84m sale to UDG plc and Hive on its £50m sale to St Ives plc. Anthony also sits on the awards judging panel for healthcare industry body Communiqué.
Away from work, Anthony is a keen rugby player.